Identification from a positional scanning peptoid library of in vivo active compounds that neutralize bacterial endotoxins

Journal of Medicinal Chemistry

Volumn 48, Issue 4, 2005, Pages 1265-1268

  Mora, Puig ^a   Masip, Isabel ^b   Cortés, Nuria ^b   Marquina, Regina ^c   Merino, Ramón ^c   Merino, Jesús ^c   Carbonell, Teresa ^a   Mingarro, Ismael ^a   Messeguer, Angel ^b   Pérez Payá, Enrique ^d  

^a UNIVERSITY OF VALENCIA   (Spain)

^b DEPARTMENT OF ENVIRONMENTAL CHEMISTRY   (Spain)

^c UNIVERSITY OF CANTABRIA   (Spain)

^d CSIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CARBOHYDRATE; ENDOTOXIN; LIPID A; PEPTIDE LIBRARY; PEPTOID; POSITIONAL SCANNING PEPTOID LIBRARY; UNCLASSIFIED DRUG;

ARTICLE; ENDOTOXEMIA; HYDROPHILICITY; HYDROPHOBICITY; IN VIVO STUDY; MICELLE; PROTEIN ANALYSIS; PROTEIN BINDING; SCREENING;

ANIMALS; DATABASES, FACTUAL; GRAM-NEGATIVE BACTERIA; LIPID A; LIPOPOLYSACCHARIDES; MICE; PEPTOIDS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 13944275512     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm040834i     Document Type: Article

References (30)

1. Rietschel, E. T.; Brade, H.; Holst, O.; Brade, L.; Muller-Loennies, S.; Mamat, U.; Zahringer, U.; Beckmann, F.; Seydel, U.; Brandenburg, K.; Ulmer, A. J.; Mattern, T.; Heine, H.; Schletter, J.; Loppnow, H.; Schonbeck, U.; Flad, H. D.; Hauschildt, S.; Schade, U. F.; Di Padova, F.; Kusumoto, S.; Schumann, R. R. Bacterial endotoxin: Chemical constitution, biological recognition, host response, and immunological detoxification. Curr. Top. Microbiol. Immunol. 1996, 216, 39-81.
2. Heine, H.; Rietschel, E. T.; Ulmer, A. J. The biology of endotoxin. Mol. Biotechnol. 2001, 19, 279-296.
3. Yu, B.; Wright, S. D. Catalytic properties of lipopolysaccharide (LPS) binding protein. Transfer of LPS to soluble CD14. J. Biol. Chem. 1998, 271, 4100-4105.
4. Ulevitch, R. J.; Tobias, P. S. Recognition of Gram-negative bacteria and endotoxin by the innate immune system. Curr. Opin. Immunol. 1999, 11, 19-22.
5. Gough, M.; Hancock, R. E.; Kelly, N. M. Antiendotoxin activity of cationic peptide antimicrobial agents. Infect. Immun. 1996, 64, 4922-4927.
6. Fidai, S.; Farmer, S. W.; Hancock, R. E. Interaction of cationic peptides with bacterial membranes. Methods Mol. Biol. 1997, 78, 187-204.
7. Scott, M. G.; Vreugdenhil, A. C.; Buurman, W. A.; Hancock, R. E.; Gold, M. R. Cutting edge: cationic antimicrobial peptides block the binding of lipopolysaccharide (LPS) to LPS binding protein. J. Immunol. 2000, 164, 549-553.
8. Nagaoka, I.; Hirota, S.; Niyonsaba, F.; Hirata, M.; Adachi, Y.; Tamura, H.; Tanaka, S.; Heumann, D. Augmentation of the lipopolysaccharide-neutralizing activities of human cathelicidin CAP18/LL-37-derived antimicrobial peptides by replacement with hydrophobic and cationic amino acid residues. Clin. Diagn. Lab. Immunol. 2002, 9, 972-982.
9. Wurfel, M. M.; Hailman, E.; Wright, S. D. Soluble CD14 acts as a shuttle in the neutralization of lipopolysaccharide (LPS) by LPS-binding protein and reconstituted high density lipoprotein. J. Exp. Med. 1995, 181, 1743-1754.
10. Burkoth, T. S.; Fafarman, A. T.; Charych, D. H.; Connolly, M. D.; Zuckermann, R. N. Incorporation of unprotected heterocyclic side chains into peptoid oligomers via solid-phase submonomer synthesis. J. Am. Chem. Soc. 2003, 125, 8841-8845.
11. Pinilla, C.; Appel, J. R.; Blanc, P.; Houghten, R. A. Rapid identification of high affinity peptide ligands using positional scanning synthetic peptide combinatorial libraries. BioTechniques 1992, 13, 901-905.
12. Humet, M.; Carbonell, T.; Masip, I.; Sanchez-Baeza, F.; Mora, P.; Canton, E.; Gobernado, M.; Abad, C.; Perez-Paya, E.; Messeguer, A. A positional scanning combinatorial library of peptoids as a source of biological active molecules: identification of antimicrobials. J. Comb. Chem. 2003, 5, 597-605.
13. García-Martínez, C.; Humet, M.; Planells-Cases, R.; Gomis, A.; Caprini, M.; Viana, F.; De la Peña, E.; Sanchez-Baeza, F.; Carbonell, T.; De Felipe, C.; Pérez-Payá, E.; Belmonte, C.; Messeguer, A.; Ferrer-Montiel, A. Attenuation of thermal nociception and hyperalgesia by VRI blockers. Proc. Natl. Acad. Sci. U.S.A. 2002, 99, 2374-2379.
14. Planells-Cases, R.; Montoliu, C.; Humet, M.; Fernandez, A. M.; Garcia-Martinez, C.; Valera, E.; Merino, J. M.; Perez-Paya, E.; Messeguer, A.; Felipo, V.; Ferrer-Montiel, A. A novel N-methyl-D-aspartate receptor open channel blocker with in vivo neuroprotectant activity. J. Pharmacol. Exp. Ther. 2002, 302, 163-173.
15. Montoliu, C.; Humet, M.; Canales, J. J.; Burda, J.; Planells-Cases, R.; Sanchez-Baeza, F.; Carbonell, T.; Perez-Paya, E.; Messeguer, A.; Ferrer-Montiel, A.; Felipo, V. Prevention of in vivo excitotoxicity by a family of trialkylglycines, a novel class of neuroprotectants. J. Pharmacol. Exp. Ther. 2002, 301, 29-36.
16. Gonzalez-Navarro, H.; Mora, P.; Pastor, M.; Serrano, L.; Mingarro, I.; Perez-Paya, E. Identification of peptides that neutralize bacterial endotoxins using beta-hairpin conformationally restricted libraries. Mol. Diversity 2000, 5, 117-126.
17. Morrison, D. C.; Jacobs, D. M. Binding of polymyxin B to the lipid A portion of bacterial lipopolysaccharides. Immunochemistry 1976, 13, 813-818.
18. Ried, C.; Wahl, C.; Miethke, T.; Wellnhofer, G.; Landgraf, C.; Schneider-Mergener, J.; Hoess, A. High affinity endotoxin-binding and neutralizing peptides based on the crystal structure of recombinant Limulus anti-lipopolysaccharide factor. J. Biol. Chem. 1996, 271, 28120-28127.
19. Ulevitch, R. J.; Tobias, P. S. Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin. Annu. Rev. Immunol. 1995, 13, 437-457.
20. Rustici, A.; Velucchi, M.; Faggioni, R.; Sironi, M.; Ghezzi, P.; Quataert, S.; Green, B.; Porro, M. Molecular mapping and detoxification of the lipid A binding site by synthetic peptides. Science 1993, 259, 361-365.
21. Kloczewiak, M.; Black, K. M.; Loiselle, P.; Cavaillon, J. M.; Wainwright, N.; Warren, H. S. Synthetic peptides that mimic the binding site of horseshoe crab antilipopolysaccharide factor. J. Infect. Dis. 1994, 170, 1490-1497.
22. Larrick, J. W.; Hirata, M.; Zheng, H.; Zhong, J.; Bolin, D.; Cavaillon, J. M.; Warren, H. S.; Wright, S. C. A novel granulocyte-derived peptide with lipopolysaccharide-neutralizing activity. J. Immunol. 1994, 152, 231-240.
23. Taylor, A. H.; Heavner, G.; Nedelman, M.; Sherris, D.; Brunt, E.; Knight, D.; Ghrayeb, J. Lipopolysaccharide (LPS) neutralizing peptides reveal a lipid A binding site of LPS binding protein. J. Biol. Chem. 1995, 270, 17934-17938.
24. Dalfo, E.; Hernandez, M.; Lizcano, J. M.; Tipton, K. F.; Unzeta, M. Activation of human lung semicarbazide sensitive amine oxidase by a low molecular weight component present in human plasma. Biochim. Biophys. Acta 2003, 1638, 278-286.
25. Tyteca, D.; Schanck, A.; Dufrene, Y. F.; Deleu, M.; Courtoy, P. J.; Tulkens, P. M.; Mingeot-Leclercq, M. P. The macrolide antibiotic azithromycin interacts with lipids and affects membrane organization and fluidity: studies on Langmuir-Blodgett monolayers, liposomes and J774 macrophages. J. Membr. Biol. 2003, 192, 203-215.
26. Zhang, X.; Jackson, J. K.; Burt, H. M. Determination of surfactant critical micelle concentration by a novel fluorescence depolarization technique. J. Biochem. Biophys. Methods 1996, 31, 145-150.
27. Webb, S. The role of mediators in sepsis resolution. Adv. Sepsis 2002, 2, 8-14.
28. Tsubery, H.; Ofek, I.; Cohen, S.; Fridkin, M. Structure-function studies of polymyxin B nonapeptide: implications to sensitization of Gram-negative bacteria. J. Med. Chem. 2000, 43, 3085-3092.
29. Taylor, P. W.; Stapleton, P. D.; Paul Luzio, J. New ways to treat bacterial infections. Drug Discovery Today 2002, 7, 1086-1091.
30. Vaara, M.; Vaara, T. Sensitization of Gram-negative bacteria to antibiotics and complement by a nontoxic oligopeptide. Nature 1983, 303, 526-528.